Patents by Inventor Margaret Lynn Bjerke

Margaret Lynn Bjerke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110135629
    Abstract: Human MPTENAKT genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of MPTENAKT are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: June 9, 2011
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Publication number: 20100183583
    Abstract: Human GALK1 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of GALK1 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 22, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Publication number: 20100122354
    Abstract: Human CDC6 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of CDC6 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: May 13, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake